Recently, more attention has been given to breast implants and their long-term effects on the body. As a patient and consumer, it’s important to understand the possible risks and developments that come with a transformative procedure such as breast augmentation. At Mosharrafa Plastic Surgery, we ensure each of our patients understand the signs and symptoms of breast implant-related complications, even if it comes with very low risk.
BII, or breast implant illness, describes a set of symptoms that women sometimes experience after receiving breast implants. While these symptoms are real, their link to breast implants needs further study. To date, no scientific information exists linking smooth-lined saline or silicone implants to any form of human disease.
Anaplastic Large Cell Lymphoma (ALCL) is a rare disorder that has been linked to textured-surface breast implants. The introduction of ALCL over a decade ago has prompted new concerns about breast implant safety, and more recently, certain textured implants were recalled from use in breast augmentation and reconstruction. ALCL usually presents around 8 years or more after implantation with the fluid collection and swelling around the implant. It is curable with early diagnosis and removal of the implant and capsule. We continue to learn more with ongoing research about ALCL.
There are two different types of textured implants which are called macro-textured implants and micro-textured implants. We no longer use macro-textured implants. Micro-textured implants are not among the types of textured implants that were recently recalled.
Questions about the safety of silicone breast implants have a long history. In the late 1980s, questions arose about the links between silicone implant leaks and autoimmune disease. In February 1992, an FDA moratorium removed silicone implants from the open market while this issue was studied closely. Over the next 14 years, over 190,000 women were studied in multiple academic centers and it was concluded there was no correlation between silicone implants and the multiple diseases in question. The FDA then reversed its moratorium, returning the implants to the open market in November 2006. Ongoing studies continue to monitor these patients to follow up on these important studies. We now have more scientific data on the breast implant than any other device implanted in the human body.
Breast Implant Illness still requires a lot of studies. However, it’s important to know the risks before you opt for implant surgery. We remain committed to providing our breast implant patients the most up-to-date information and the safest care possible. If you’re considering breast augmentation, our board-certified plastic surgeons can partner with you to make sure you remain informed, safe, and healthy. To meet with our plastic surgeons and learn more about your options, contact our Phoenix office by calling or filling out our online form.